PDCD1 and glioblastoma: By contrast, another study using mass cytometry to profile the immune landscape in a smaller GBM cohort reported only a modest IFN-γ–driven immune response and found no significant changes in immune cell composition, T cell infiltration, or suppression of immunosuppressive myeloid populations following PD-1 blockade [17].